169 related articles for article (PubMed ID: 38319516)
1. Prognostic Value of Myosteatosis and Creatinine-to-Cystatin C Ratio in Patients with Pancreatic Cancer Who Underwent Radical Surgery.
Bi S; Jiang Y; Guan G; Sun X; Wang X; Zhang L; Jing X
Ann Surg Oncol; 2024 May; 31(5):2913-2924. PubMed ID: 38319516
[TBL] [Abstract][Full Text] [Related]
2. The coexistence of myosteatosis and the creatinine/cystatin C ratio are determinants of outcomes in cholangiocarcinoma patients undergoing curative surgery.
Liu Y; Zhang J; Song G; Ding X; Sun H; Zhou J; Jing X
Front Oncol; 2024; 14():1233768. PubMed ID: 38706605
[TBL] [Abstract][Full Text] [Related]
3. Creatinine-to-cystatin C ratio and body composition predict response to PD-1 inhibitors-based combination treatment in metastatic gastric cancer.
Ji H; Liu B; Jin P; Li Y; Cui L; Jin S; Wu J; Shan Y; Zhang Z; Ming J; Zhang L; Du C
Front Immunol; 2024; 15():1364728. PubMed ID: 38665913
[TBL] [Abstract][Full Text] [Related]
4. Sarcopenia and myosteatosis diagnostic tool for gastrointestinal cancer: creatinine to cystatin C ratio as evaluation marker.
Liu H; Wang J; Tan S; Zhang Z; Yan M; Han J; Sui X; Yang F; Wu G
J Transl Med; 2023 Oct; 21(1):744. PubMed ID: 37864250
[TBL] [Abstract][Full Text] [Related]
5. CD3+/CD4+ cells combined with myosteatosis predict the prognosis in patients who underwent gastric cancer surgery.
Du Z; Xiao Y; Deng G; Song H; Xue Y; Song H
J Cachexia Sarcopenia Muscle; 2024 Jun; ():. PubMed ID: 38894548
[TBL] [Abstract][Full Text] [Related]
6. ASO Author Reflections: Impact of Myosteatosis and Creatinine-to-Cystatin C Ratio on Prognosis After Pancreatic Radical Surgery.
Bi S; Jing X
Ann Surg Oncol; 2024 May; 31(5):2963-2964. PubMed ID: 38334850
[No Abstract] [Full Text] [Related]
7. Prognostic Value of Artificial Intelligence-Driven, Computed Tomography-Based, Volumetric Assessment of the Volume and Density of Muscle in Patients With Colon Cancer.
Kim M; Lee SM; Son IT; Park T; Oh BY
Korean J Radiol; 2023 Sep; 24(9):849-859. PubMed ID: 37634640
[TBL] [Abstract][Full Text] [Related]
8. Myosteatosis predicts prognosis after radical gastrectomy for gastric cancer: A propensity score-matched analysis from a large-scale cohort.
Zhuang CL; Shen X; Huang YY; Zhang FM; Chen XY; Ma LL; Chen XL; Yu Z; Wang SL
Surgery; 2019 Sep; 166(3):297-304. PubMed ID: 31072665
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of systemic immune-inflammation index and platelet-albumin-bilirubin grade in patients with pancreatic cancer undergoing radical surgery.
Han R; Tian Z; Jiang Y; Guan G; Sun X; Yu Y; Zhang L; Zhou J; Jing X
Gland Surg; 2022 Mar; 11(3):576-587. PubMed ID: 35402206
[TBL] [Abstract][Full Text] [Related]
10. Creatinine-to-cystatin C ratio as a marker of skeletal muscle mass for predicting postoperative complications in patients undergoing gastric cancer surgery.
Gao J; Liang H; Qian Y; Pan J; Liu W; Qi W; Zhou W; Ge X; Wang X
Ann Palliat Med; 2021 May; 10(5):5017-5026. PubMed ID: 33894713
[TBL] [Abstract][Full Text] [Related]
11. Serum creatinine and cystatin C-based diagnostic indices for sarcopenia in advanced non-small cell lung cancer.
Tang T; Xie L; Hu S; Tan L; Lei X; Luo X; Yang L; Yang M
J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1800-1810. PubMed ID: 35297568
[TBL] [Abstract][Full Text] [Related]
12. Association of Albumin-Bilirubin Grade and Myosteatosis with its Prognostic Significance for Patients with Colorectal Cancer.
Koh HH; Cho ES; Lee JH; Shin SJ; Lee HS; Park EJ; Baik SH; Lee KY; Kang J
Ann Surg Oncol; 2022 Jun; 29(6):3868-3876. PubMed ID: 35211856
[TBL] [Abstract][Full Text] [Related]
13. Clinical implications and predictive value of the creatinine‑cystatin C ratio in patients with multiple myeloma and renal impairment.
Sun Y; Zhao J; Du J; Li Y; Ding F; Zhao W
Oncol Lett; 2024 Mar; 27(3):134. PubMed ID: 38362231
[TBL] [Abstract][Full Text] [Related]
14. Impact of preoperative sarcopenia and myosteatosis on prognosis after radical cystectomy in patients with bladder cancer.
Yamashita S; Iguchi T; Koike H; Wakamiya T; Kikkawa K; Kohjimoto Y; Hara I
Int J Urol; 2021 Jul; 28(7):757-762. PubMed ID: 33821510
[TBL] [Abstract][Full Text] [Related]
15. Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma.
Chen BB; Liang PC; Shih TT; Liu TH; Shen YC; Lu LC; Lin ZZ; Hsu C; Hsu CH; Cheng AL; Shao YY
Eur Radiol; 2023 Jan; 33(1):512-522. PubMed ID: 35864351
[TBL] [Abstract][Full Text] [Related]
16. The Prognostic Value of Sarcopenia and Myosteatosis in Biliary Tract Cancer After Palliative Treatment With Radiation-Emitting Metallic Stent.
Chen Q; Lu J; Lu X; Yao XJ; Zhang XP; Wang SY; Guo JH
Front Surg; 2022; 9():852137. PubMed ID: 35558381
[TBL] [Abstract][Full Text] [Related]
17. Combined impact of myosteatosis and liver steatosis on prognosis in stage I-III colorectal cancer patients.
Lee DH; Jo I; Lee HS; Kang J
J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2908-2915. PubMed ID: 37964719
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the influence of sarcopenia and myosteatosis on clinical outcomes in gastric cancer patients undergoing immune checkpoint inhibitor.
Deng GM; Song HB; Du ZZ; Xue YW; Song HJ; Li YZ
World J Gastroenterol; 2024 Feb; 30(8):863-880. PubMed ID: 38516238
[TBL] [Abstract][Full Text] [Related]
19. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
Rollins KE; Tewari N; Ackner A; Awwad A; Madhusudan S; Macdonald IA; Fearon KC; Lobo DN
Clin Nutr; 2016 Oct; 35(5):1103-9. PubMed ID: 26411749
[TBL] [Abstract][Full Text] [Related]
20. Deep learning-based assessment of CT markers of sarcopenia and myosteatosis for outcome assessment in patients with advanced pancreatic cancer after high-intensity focused ultrasound treatment.
Nowak S; Kloth C; Theis M; Marinova M; Attenberger UI; Sprinkart AM; Luetkens JA
Eur Radiol; 2024 Jan; 34(1):279-286. PubMed ID: 37572195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
